| Year |
Citation |
Score |
| 2024 |
Fenis A, Demaria O, Gauthier L, Vivier E, Narni-Mancinelli E. New immune cell engagers for cancer immunotherapy. Nature Reviews. Immunology. PMID 38273127 DOI: 10.1038/s41577-023-00982-7 |
0.347 |
|
| 2024 |
Narni-Mancinelli E, Berruyer C, Vivier E. On blood and tissue-resident natural killer cells. Immunity. 57: 6-8. PMID 38198854 DOI: 10.1016/j.immuni.2023.12.013 |
0.379 |
|
| 2023 |
Vetters J, van Helden M, De Nolf C, Rennen S, Cloots E, Van De Velde E, Fayazpour F, Van Moorleghem J, Vanheerswynghels M, Vergote K, Boon L, Vivier E, Lambrecht BN, Janssens S. Canonical IRE1 function needed to sustain vigorous natural killer cell proliferation during viral infection. Iscience. 26: 108570. PMID 38162021 DOI: 10.1016/j.isci.2023.108570 |
0.478 |
|
| 2023 |
Playoust E, Remark R, Vivier E, Milpied P. Germinal center-dependent and -independent immune responses of tumor-infiltrating B cells in human cancers. Cellular & Molecular Immunology. 20: 1040-1050. PMID 37419983 DOI: 10.1038/s41423-023-01060-7 |
0.381 |
|
| 2023 |
Khameneh HJ, Fonta N, Zenobi A, Niogret C, Ventura P, Guerra C, Kwee I, Rinaldi A, Pecoraro M, Geiger R, Cavalli A, Bertoni F, Vivier E, Trumpp A, Guarda G. Myc controls NK cell development, IL-15-driven expansion, and translational machinery. Life Science Alliance. 6. PMID 37105715 DOI: 10.26508/lsa.202302069 |
0.519 |
|
| 2023 |
Carrette F, Vivier E. NKG2A blocks the anti-metastatic functions of natural killer cells. Cancer Cell. 41: 232-234. PMID 36787695 DOI: 10.1016/j.ccell.2023.01.008 |
0.35 |
|
| 2023 |
Gauthier L, Virone-Oddos A, Beninga J, Rossi B, Nicolazzi C, Amara C, Blanchard-Alvarez A, Gourdin N, Courta J, Basset A, Agnel M, Guillot F, Grondin G, Bonnevaux H, Bauchet AL, ... ... Vivier E, et al. Control of acute myeloid leukemia by a trifunctional NKp46-CD16a-NK cell engager targeting CD123. Nature Biotechnology. PMID 36635380 DOI: 10.1038/s41587-022-01626-2 |
0.34 |
|
| 2023 |
Lopes N, Vivier E, Narni-Mancinelli E. Natural killer cells and type 1 innate lymphoid cells in cancer. Seminars in Immunology. 66: 101709. PMID 36621291 DOI: 10.1016/j.smim.2022.101709 |
0.578 |
|
| 2023 |
Vivier E. The discovery of innate lymphoid cells. Nature Reviews. Immunology. 21: 616. PMID 34580448 DOI: 10.1038/s41577-021-00595-y |
0.499 |
|
| 2022 |
Lopes N, Galluso J, Escalière B, Carpentier S, Kerdiles YM, Vivier E. Tissue-specific transcriptional profiles and heterogeneity of natural killer cells and group 1 innate lymphoid cells. Cell Reports. Medicine. 3: 100812. PMID 36384102 DOI: 10.1016/j.xcrm.2022.100812 |
0.503 |
|
| 2022 |
Demaria O, Gauthier L, Vetizou M, Blanchard Alvarez A, Vagne C, Habif G, Batista L, Baron W, Belaïd N, Girard-Madoux M, Cesari C, Caratini M, Bosco F, Benac O, Lopez J, ... ... Vivier E, et al. Antitumor immunity induced by antibody-based natural killer cell engager therapeutics armed with not-alpha IL-2 variant. Cell Reports. Medicine. 3: 100783. PMID 36260981 DOI: 10.1016/j.xcrm.2022.100783 |
0.511 |
|
| 2022 |
Medjouel Khlifi H, Guia S, Vivier E, Narni-Mancinelli E. Role of the ITAM-Bearing Receptors Expressed by Natural Killer Cells in Cancer. Frontiers in Immunology. 13: 898745. PMID 35757695 DOI: 10.3389/fimmu.2022.898745 |
0.536 |
|
| 2022 |
Bernard PL, Delconte R, Pastor S, Laletin V, Costa Da Silva C, Goubard A, Josselin E, Castellano R, Krug A, Vernerey J, Devillier R, Olive D, Verhoeyen E, Vivier E, Huntington ND, et al. Targeting CISH enhances natural cytotoxicity receptor signaling and reduces NK cell exhaustion to improve solid tumor immunity. Journal For Immunotherapy of Cancer. 10. PMID 35589278 DOI: 10.1136/jitc-2021-004244 |
0.502 |
|
| 2022 |
Narni-Mancinelli E, Vivier E. Advancing natural killer therapies against cancer. Cell. 185: 1451-1454. PMID 35487189 DOI: 10.1016/j.cell.2022.04.006 |
0.355 |
|
| 2022 |
Jacquelot N, Seillet C, Vivier E, Belz GT. Innate lymphoid cells and cancer. Nature Immunology. 23: 371-379. PMID 35228695 DOI: 10.1038/s41590-022-01127-z |
0.403 |
|
| 2022 |
Fumagalli V, Venzin V, Di Lucia P, Moalli F, Ficht X, Ambrosi G, Giustini L, Andreata F, Grillo M, Magini D, Ravà M, Friedrich C, Fontenot JD, Bousso P, Gilmore SA, ... ... Vivier E, et al. Group 1 ILCs regulate T cell-mediated liver immunopathology by controlling local IL-2 availability. Science Immunology. 7: eabi6112. PMID 35213210 DOI: 10.1126/sciimmunol.abi6112 |
0.436 |
|
| 2022 |
Colomar-Carando N, Gauthier L, Merli P, Loiacono F, Canevali P, Falco M, Galaverna F, Rossi B, Bosco F, Caratini M, Mingari MC, Locatelli F, Vivier E, Meazza R, Pende D. Exploiting Natural Killer Cell Engagers to Control Pediatric B-cell Precursor Acute Lymphoblastic Leukemia. Cancer Immunology Research. 10: 291-302. PMID 35078821 DOI: 10.1158/2326-6066.CIR-21-0843 |
0.509 |
|
| 2022 |
Lopes N, Vivier E. Natural killer cells lull tumours into dormancy. Nature. 594: 501-502. PMID 34079112 DOI: 10.1038/d41586-021-01381-5 |
0.42 |
|
| 2021 |
Vienne M, Etiennot M, Escalière B, Galluso J, Spinelli L, Guia S, Fenis A, Vivier E, Kerdiles YM. Type 1 Innate Lymphoid Cells Limit the Antitumoral Immune Response. Frontiers in Immunology. 12: 768989. PMID 34868026 DOI: 10.3389/fimmu.2021.768989 |
0.436 |
|
| 2021 |
Narni-Mancinelli E, Vivier E. Clues that natural killer cells help to control COVID. Nature. 600: 226-227. PMID 34697480 DOI: 10.1038/d41586-021-02778-y |
0.376 |
|
| 2021 |
Cazzetta V, Bruni E, Terzoli S, Carenza C, Franzese S, Piazza R, Marzano P, Donadon M, Torzilli G, Cimino M, Simonelli M, Bello L, Villa A, Tan L, Ravens S, ... ... Vivier E, et al. NKG2A expression identifies a subset of human Vδ2 T cells exerting the highest antitumor effector functions. Cell Reports. 37: 109871. PMID 34686325 DOI: 10.1016/j.celrep.2021.109871 |
0.385 |
|
| 2021 |
Crinier A, Dumas PY, Escalière B, Piperoglou C, Gil L, Villacreces A, Vély F, Ivanovic Z, Milpied P, Narni-Mancinelli É, Vivier É. Correction: Single-cell profiling reveals the trajectories of natural killer cell differentiation in bone marrow and a stress signature induced by acute myeloid leukemia. Cellular & Molecular Immunology. 18: 2578-2580. PMID 34588630 DOI: 10.1038/s41423-021-00771-z |
0.301 |
|
| 2021 |
Qi J, Crinier A, Escalière B, Ye Y, Wang Z, Zhang T, Batista L, Liu H, Hong L, Wu N, Zhang M, Chen L, Liu Y, Shen L, Narni-Mancinelli E, ... Vivier E, et al. Single-cell transcriptomic landscape reveals tumor specific innate lymphoid cells associated with colorectal cancer progression. Cell Reports. Medicine. 2: 100353. PMID 34467243 DOI: 10.1016/j.xcrm.2021.100353 |
0.372 |
|
| 2021 |
Tang Y, Xu Q, Hu L, Yan X, Feng X, Yokota A, Wang W, Zhan D, Krishnamurthy D, Ochayon DE, Wen L, Huo L, Zeng H, Luo Y, Huang LF, ... ... Vivier E, et al. Tumor Microenvironment-Derived R-spondins Enhance Anti-Tumor Immunity to Suppress Tumor Growth and Sensitize for Immune Checkpoint Blockade Therapy. Cancer Discovery. PMID 34193438 DOI: 10.1158/2159-8290.CD-20-0833 |
0.367 |
|
| 2021 |
Tata A, Dodard G, Fugère C, Leget C, Ors M, Rossi B, Vivier E, Brossay L. Combination blockade of KLRG1 and PD-1 promotes immune control of local and disseminated cancers. Oncoimmunology. 10: 1933808. PMID 34188973 DOI: 10.1080/2162402X.2021.1933808 |
0.356 |
|
| 2021 |
Demaria O, Gauthier L, Debroas G, Vivier E. Natural killer cell engagers in cancer immunotherapy: Next generation of immuno-oncology treatments. European Journal of Immunology. PMID 34145579 DOI: 10.1002/eji.202048953 |
0.31 |
|
| 2021 |
Jacquelot N, Seillet C, Wang M, Pizzolla A, Liao Y, Hediyeh-Zadeh S, Grisaru-Tal S, Louis C, Huang Q, Schreuder J, Souza-Fonseca-Guimaraes F, de Graaf CA, Thia K, Macdonald S, Camilleri M, ... ... Vivier E, et al. Blockade of the co-inhibitory molecule PD-1 unleashes ILC2-dependent antitumor immunity in melanoma. Nature Immunology. PMID 34099918 DOI: 10.1038/s41590-021-00943-z |
0.378 |
|
| 2021 |
Devillier R, Calmels B, Guia S, Taha M, Fauriat C, Mfarrej B, Venton G, Vivier E, Olive D, Chabannon C, Blaise D, Ugolini S. Phase I Trial of Prophylactic Donor-Derived IL-2-Activated NK Cell Infusion after Allogeneic Hematopoietic Stem Cell Transplantation from a Matched Sibling Donor. Cancers. 13. PMID 34071607 DOI: 10.3390/cancers13112673 |
0.421 |
|
| 2021 |
Crinier A, Escalière B, Narni-Mancinelli E, Vivier E. Reply to 'Comment to: Single-cell profiling reveals the trajectories of natural killer cell differentiation in bone marrow and a stress signature induced by acute myeloid leukemia'. Cellular & Molecular Immunology. 18: 1350-1352. PMID 33893393 DOI: 10.1038/s41423-021-00678-9 |
0.301 |
|
| 2021 |
Piperoglou C, Larid G, Vallentin B, Balligand L, Crinier A, Banzet N, Farnarier C, Gomez-Massa E, Adalia AC, Michel G, Galambrun C, Barlogis V, Vivier E, Vély F. Innate lymphoid cell recovery and occurrence of GvHD after hematopoietic stem cell transplantation. Journal of Leukocyte Biology. PMID 33847423 DOI: 10.1002/JLB.5A1019-522RR |
0.421 |
|
| 2021 |
Vanderkerken M, Baptista AP, De Giovanni M, Fukuyama S, Browaeys R, Scott CL, Norris PS, Eberl G, Di Santo JP, Vivier E, Saeys Y, Hammad H, Cyster JG, Ware CF, Tumanov AV, et al. ILC3s control splenic cDC homeostasis via lymphotoxin signaling. The Journal of Experimental Medicine. 218. PMID 33724364 DOI: 10.1084/jem.20190835 |
0.348 |
|
| 2021 |
Dodard G, Tata A, Erick TK, Jaime D, Miah SMS, Quatrini L, Escalière B, Ugolini S, Vivier E, Brossay L. Inflammation-Induced Lactate Leads to Rapid Loss of Hepatic Tissue-Resident NK Cells. Cell Reports. 32: 107855. PMID 32640221 DOI: 10.1016/j.celrep.2020.107855 |
0.431 |
|
| 2020 |
Cózar B, Greppi M, Carpentier S, Narni-Mancinelli E, Chiossone L, Vivier E. Tumor-Infiltrating Natural Killer Cells. Cancer Discovery. PMID 33277307 DOI: 10.1158/2159-8290.CD-20-0655 |
0.426 |
|
| 2020 |
Crinier A, Kerdiles Y, Vienne M, Cózar B, Vivier E, Berruyer C. Multidimensional molecular controls defining NK/ILC1 identity in cancers. Seminars in Immunology. 101424. PMID 33272899 DOI: 10.1016/j.smim.2020.101424 |
0.548 |
|
| 2020 |
Crinier A, Dumas PY, Escalière B, Piperoglou C, Gil L, Villacreces A, Vély F, Ivanovic Z, Milpied P, Narni-Mancinelli É, Vivier É. Single-cell profiling reveals the trajectories of natural killer cell differentiation in bone marrow and a stress signature induced by acute myeloid leukemia. Cellular & Molecular Immunology. 18: 1290-1304. PMID 33239726 DOI: 10.1038/s41423-020-00574-8 |
0.486 |
|
| 2020 |
Seillet C, Brossay L, Vivier E. Natural killers or ILC1s? That is the question. Current Opinion in Immunology. 68: 48-53. PMID 33069142 DOI: 10.1016/j.coi.2020.08.009 |
0.521 |
|
| 2020 |
Demaria O, Carvelli J, Batista L, Thibult ML, Morel A, André P, Morel Y, Vély F, Vivier E. Identification of druggable inhibitory immune checkpoints on Natural Killer cells in COVID-19. Cellular & Molecular Immunology. PMID 32612152 DOI: 10.1038/s41423-020-0493-9 |
0.399 |
|
| 2020 |
Crinier A, Narni-Mancinelli E, Ugolini S, Vivier E. SnapShot: Natural Killer Cells. Cell. 180: 1280-1280.e1. PMID 32200803 DOI: 10.1016/j.cell.2020.02.029 |
0.466 |
|
| 2020 |
Mack MR, Brestoff JR, Berrien-Elliott MM, Trier AM, Yang TB, McCullen M, Collins PL, Niu H, Bodet ND, Wagner JA, Park E, Xu AZ, Wang F, Chibnall R, Council ML, ... ... Vivier E, et al. Blood natural killer cell deficiency reveals an immunotherapy strategy for atopic dermatitis. Science Translational Medicine. 12. PMID 32102931 DOI: 10.1126/Scitranslmed.Aay1005 |
0.41 |
|
| 2020 |
Louis C, Guimaraes F, Yang Y, D'Silva D, Kratina T, Dagley L, Hediyeh-Zadeh S, Rautela J, Masters SL, Davis MJ, Babon JJ, Ciric B, Vivier E, Alexander WS, Huntington ND, et al. NK cell-derived GM-CSF potentiates inflammatory arthritis and is negatively regulated by CIS. The Journal of Experimental Medicine. 217. PMID 32097462 DOI: 10.1084/jem.20191421 |
0.4 |
|
| 2019 |
van Hall T, André P, Horowitz A, Ruan DF, Borst L, Zerbib R, Narni-Mancinelli E, van der Burg SH, Vivier E. Monalizumab: inhibiting the novel immune checkpoint NKG2A. Journal For Immunotherapy of Cancer. 7: 263. PMID 31623687 DOI: 10.1186/s40425-019-0761-3 |
0.336 |
|
| 2019 |
Rautela J, Dagley LF, de Oliveira CC, Schuster IS, Hediyeh-Zadeh S, Delconte RB, Cursons J, Hennessy R, Hutchinson DS, Harrison C, Kita B, Vivier E, Webb AI, Degli-Esposti MA, Davis MJ, et al. Therapeutic blockade of activin-A improves NK cell function and antitumor immunity. Science Signaling. 12. PMID 31455725 DOI: 10.1126/scisignal.aat7527 |
0.494 |
|
| 2019 |
Vetters J, van Helden MJ, Wahlen S, Tavernier SJ, Martens A, Fayazpour F, Vergote K, Vanheerswynghels M, Deswarte K, Van Moorleghem J, De Prijck S, Takahashi N, Vandenabeele P, Boon L, van Loo G, ... Vivier E, et al. The ubiquitin-editing enzyme A20 controls NK cell homeostasis through regulation of mTOR activity and TNF. The Journal of Experimental Medicine. 216: 2010-2023. PMID 31296735 DOI: 10.1084/jem.20182164 |
0.383 |
|
| 2019 |
Dou Y, Xing J, Kong G, Wang G, Lou X, Xiao X, Vivier E, Li XC, Zhang Z. Identification of the E3 Ligase TRIM29 as a Critical Checkpoint Regulator of NK Cell Functions. Journal of Immunology (Baltimore, Md. : 1950). PMID 31270148 DOI: 10.4049/jimmunol.1900171 |
0.54 |
|
| 2019 |
Gauthier L, Morel A, Anceriz N, Rossi B, Blanchard-Alvarez A, Grondin G, Trichard S, Cesari C, Sapet M, Bosco F, Rispaud-Blanc H, Guillot F, Cornen S, Roussel A, Amigues B, ... ... Vivier E, et al. Multifunctional Natural Killer Cell Engagers Targeting NKp46 Trigger Protective Tumor Immunity. Cell. 177: 1701-1713.e16. PMID 31155232 DOI: 10.1016/j.cell.2019.04.041 |
0.329 |
|
| 2019 |
Hillion S, Arleevskaya MI, Blanco P, Bordron A, Brooks WH, Cesbron JY, Kaveri S, Vivier E, Renaudineau Y. The Innate Part of the Adaptive Immune System. Clinical Reviews in Allergy & Immunology. PMID 31154567 DOI: 10.1007/s12016-019-08740-1 |
0.327 |
|
| 2019 |
Crinier A, Vivier E, Bléry M. Helper-like innate lymphoid cells and cancer immunotherapy. Seminars in Immunology. PMID 31072659 DOI: 10.1016/j.smim.2019.04.002 |
0.39 |
|
| 2019 |
Cherfils-Vicini J, Iltis C, Cervera L, Pisano S, Croce O, Sadouni N, Győrffy B, Collet R, Renault VM, Rey-Millet M, Leonetti C, Zizza P, Allain F, Ghiringhelli F, Soubeiran N, ... ... Vivier E, et al. Cancer cells induce immune escape via glycocalyx changes controlled by the telomeric protein TRF2. The Embo Journal. PMID 31000523 DOI: 10.15252/embj.2018100012 |
0.34 |
|
| 2019 |
Niogret C, Miah SMS, Rota G, Fonta NP, Wang H, Held W, Birchmeier W, Sexl V, Yang W, Vivier E, Ho PC, Brossay L, Guarda G. Shp-2 is critical for ERK and metabolic engagement downstream of IL-15 receptor in NK cells. Nature Communications. 10: 1444. PMID 30926899 DOI: 10.1038/S41467-019-09431-3 |
0.42 |
|
| 2019 |
Habif G, Crinier A, André P, Vivier E, Narni-Mancinelli E. Targeting natural killer cells in solid tumors. Cellular & Molecular Immunology. PMID 30911118 DOI: 10.1038/s41423-019-0224-2 |
0.508 |
|
| 2019 |
Chiossone L, Dumas PY, Vienne M, Vivier E. Author Correction: Natural killer cells and other innate lymphoid cells in cancer. Nature Reviews. Immunology. 18: 726. PMID 30315207 DOI: 10.1038/s41577-018-0077-4 |
0.306 |
|
| 2019 |
Quatrini L, Vivier E, Ugolini S. Neuroendocrine regulation of innate lymphoid cells. Immunological Reviews. 286: 120-136. PMID 30294960 DOI: 10.1111/imr.12707 |
0.41 |
|
| 2019 |
Chiossone L, Dumas PY, Vienne M, Vivier E. Natural killer cells and other innate lymphoid cells in cancer. Nature Reviews. Immunology. 18: 671-688. PMID 30209347 DOI: 10.1038/s41577-018-0061-z |
0.522 |
|
| 2019 |
Haspeslagh E, van Helden MJ, Deswarte K, De Prijck S, van Moorleghem J, Boon L, Hammad H, Vivier E, Lambrecht BN. Role of NKp46 natural killer cells in house dust mite-driven asthma. Embo Molecular Medicine. 10. PMID 29444897 DOI: 10.15252/emmm.201708657 |
0.45 |
|
| 2018 |
André P, Denis C, Soulas C, Bourbon-Caillet C, Lopez J, Arnoux T, Bléry M, Bonnafous C, Gauthier L, Morel A, Rossi B, Remark R, Breso V, Bonnet E, Habif G, ... ... Vivier E, et al. Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells. Cell. PMID 30503213 DOI: 10.1016/j.cell.2018.10.014 |
0.465 |
|
| 2018 |
Crinier A, Milpied P, Escalière B, Piperoglou C, Galluso J, Balsamo A, Spinelli L, Cervera-Marzal I, Ebbo M, Girard-Madoux M, Jaeger S, Bollon E, Hamed S, Hardwigsen J, Ugolini S, ... ... Vivier E, et al. High-Dimensional Single-Cell Analysis Identifies Organ-Specific Signatures and Conserved NK Cell Subsets in Humans and Mice. Immunity. 49: 971-986.e5. PMID 30413361 DOI: 10.1016/j.immuni.2018.09.009 |
0.471 |
|
| 2018 |
Almeida FF, Tognarelli S, Marçais A, Kueh AJ, Friede ME, Liao Y, Willis SN, Luong K, Faure F, Mercier FE, Galluso J, Firth M, Narni-Mancinelli E, Rais B, Scadden DT, ... ... Vivier E, et al. A point mutation in the signal peptide impairs the development of innate lymphoid cell subsets. Oncoimmunology. 7: e1475875. PMID 30288342 DOI: 10.1080/2162402X.2018.1475875 |
0.507 |
|
| 2018 |
Vivier E, Artis D, Colonna M, Diefenbach A, Di Santo JP, Eberl G, Koyasu S, Locksley RM, McKenzie ANJ, Mebius RE, Powrie F, Spits H. Innate Lymphoid Cells: 10 Years On. Cell. 174: 1054-1066. PMID 30142344 DOI: 10.1016/J.Cell.2018.07.017 |
0.342 |
|
| 2018 |
Quatrini L, Wieduwild E, Escaliere B, Filtjens J, Chasson L, Laprie C, Vivier E, Ugolini S. Endogenous glucocorticoids control host resistance to viral infection through the tissue-specific regulation of PD-1 expression on NK cells. Nature Immunology. 19: 954-962. PMID 30127438 DOI: 10.1038/s41590-018-0185-0 |
0.41 |
|
| 2018 |
Vivier E, Vély F, Fischer A. Reply to 'Comment on: Evidence of innate lymphoid cell redundancy in humans'. Nature Immunology. PMID 30026478 DOI: 10.1038/s41590-018-0165-4 |
0.377 |
|
| 2018 |
Castro W, Chelbi ST, Niogret C, Ramon-Barros C, Welten SPM, Osterheld K, Wang H, Rota G, Morgado L, Vivier E, Raeber ME, Boyman O, Delorenzi M, Barras D, Ho PC, et al. The transcription factor Rfx7 limits metabolism of NK cells and promotes their maintenance and immunity. Nature Immunology. PMID 29967452 DOI: 10.1038/S41590-018-0144-9 |
0.448 |
|
| 2018 |
Guia S, Fenis A, Vivier E, Narni-Mancinelli E. Activating and inhibitory receptors expressed on innate lymphoid cells. Seminars in Immunopathology. 40: 331-341. PMID 29789862 DOI: 10.1007/s00281-018-0685-x |
0.521 |
|
| 2018 |
Nabekura T, Chen Z, Schroeder C, Park T, Vivier E, Lanier LL, Liu D. Crk Adaptor Proteins Regulate NK Cell Expansion and Differentiation during Mouse Cytomegalovirus Infection. Journal of Immunology (Baltimore, Md. : 1950). PMID 29618525 DOI: 10.4049/Jimmunol.1701639 |
0.5 |
|
| 2018 |
Rota G, Niogret C, Dang AT, Barros CR, Fonta NP, Alfei F, Morgado L, Zehn D, Birchmeier W, Vivier E, Guarda G. Shp-2 Is Dispensable for Establishing T Cell Exhaustion and for PD-1 Signaling In Vivo. Cell Reports. 23: 39-49. PMID 29617671 DOI: 10.1016/j.celrep.2018.03.026 |
0.367 |
|
| 2018 |
Ng SS, Souza-Fonseca-Guimaraes F, Rivera FL, Amante FH, Kumar R, Gao Y, Sheel M, Beattie L, Montes de Oca M, Guillerey C, Edwards CL, Faleiro RJ, Frame T, Bunn PT, Vivier E, et al. Rapid loss of group 1 innate lymphoid cells during blood stageinfection. Clinical & Translational Immunology. 7: e1003. PMID 29484181 DOI: 10.1002/Cti2.1003 |
0.401 |
|
| 2017 |
Young A, Ngiow SF, Gao Y, Patch AM, Barkauskas DS, Messaoudene M, Lin G, Coudert JD, Stannard KA, Zitvogel L, Degli-Esposti MA, Vivier E, Waddell N, Linden J, Huntington ND, et al. A2AR adenosine signaling suppresses natural killer cell maturation in the tumor microenvironment. Cancer Research. PMID 29229601 DOI: 10.1158/0008-5472.Can-17-2826 |
0.471 |
|
| 2017 |
Krzywinska E, Kantari-Mimoun C, Kerdiles Y, Sobecki M, Isagawa T, Gotthardt D, Castells M, Haubold J, Millien C, Viel T, Tavitian B, Takeda N, Fandrey J, Vivier E, Sexl V, et al. Loss of HIF-1α in natural killer cells inhibits tumour growth by stimulating non-productive angiogenesis. Nature Communications. 8: 1597. PMID 29150606 DOI: 10.1038/s41467-017-01599-w |
0.337 |
|
| 2017 |
Quatrini L, Wieduwild E, Guia S, Bernat C, Glaichenhaus N, Vivier E, Ugolini S. Host resistance to endotoxic shock requires the neuroendocrine regulation of group 1 innate lymphoid cells. The Journal of Experimental Medicine. PMID 29141867 DOI: 10.1084/jem.20171048 |
0.375 |
|
| 2017 |
Marcenaro E, Notarangelo LD, Orange JS, Vivier E. Editorial: NK Cell Subsets in Health and Disease: New Developments. Frontiers in Immunology. 8: 1363. PMID 29093717 DOI: 10.3389/Fimmu.2017.01363 |
0.303 |
|
| 2017 |
Nour-Eldine W, Joffre J, Zibara K, Esposito B, Giraud A, Zeboudj L, Vilar J, Terada M, Bruneval P, Vivier E, Ait-Oufella H, Mallat Z, Ugolini S, Tedgui A. Genetic Depletion or Hyperresponsiveness of Natural Killer Cells Do Not Affect Atherosclerosis Development. Circulation Research. 122: 47-57. PMID 29046274 DOI: 10.1161/CIRCRESAHA.117.311743 |
0.486 |
|
| 2017 |
Chiossone L, Vienne M, Kerdiles YM, Vivier E. Naturak killer cell immunotherapies against cancer: checkpoint inhibitors and more. Seminars in Immunology. PMID 28943093 DOI: 10.1016/j.smim.2017.08.003 |
0.455 |
|
| 2017 |
Marçais A, Marotel M, Degouve S, Koenig A, Fauteux-Daniel S, Drouillard A, Schlums H, Viel S, Besson L, Allatif O, Bléry M, Vivier E, Bryceson Y, Thaunat O, Walzer T. High mTOR activity is a hallmark of reactive natural killer cells and amplifies early signaling through activating receptors. Elife. 6. PMID 28875936 DOI: 10.7554/eLife.26423 |
0.478 |
|
| 2017 |
Kwong B, Rua R, Gao Y, Flickinger J, Wang Y, Kruhlak MJ, Zhu J, Vivier E, McGavern DB, Lazarevic V. T-bet-dependent NKp46(+) innate lymphoid cells regulate the onset of TH17-induced neuroinflammation. Nature Immunology. PMID 28805812 DOI: 10.1038/Ni.3816 |
0.322 |
|
| 2017 |
Gao Y, Souza-Fonseca-Guimaraes F, Bald T, Ng SS, Young A, Ngiow SF, Rautela J, Straube J, Waddell N, Blake SJ, Yan J, Bartholin L, Lee JS, Vivier E, Takeda K, et al. Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells. Nature Immunology. PMID 28759001 DOI: 10.1038/ni.3800 |
0.407 |
|
| 2017 |
Cypowyj S, Vivier É. [Innate Lymphoid Cells: new actors of immunity]. Bulletin De L'Academie Nationale De Medecine. 200: 561-72; discussion 5. PMID 28644604 |
0.518 |
|
| 2017 |
Crinier A, Viant C, Girard-Madoux M, Vivier É. [Innate lymphoid cells]. Medecine Sciences : M/S. 33: 534-542. PMID 28612730 DOI: 10.1051/medsci/20173305018 |
0.376 |
|
| 2017 |
Frazao A, Colombo M, Fourmentraux-Neves E, Messaoudene M, Rusakiewicz S, Zitvogel L, Vivier E, Vely F, Faure F, Dreno B, Benlalam H, Bouquet F, Savina A, Pasmant E, Toubert A, et al. Shifting the balance of activating and inhibitory natural killer receptor ligands on BRAF(V600E)melanoma lines with vemurafenib. Cancer Immunology Research. PMID 28576831 DOI: 10.1158/2326-6066.Cir-16-0380 |
0.478 |
|
| 2017 |
Narni-Mancinelli E, Gauthier L, Baratin M, Guia S, Fenis A, Deghmane AE, Rossi B, Fourquet P, Escalière B, Kerdiles YM, Ugolini S, Taha MK, Vivier E. Complement factor P is a ligand for the natural killer cell-activating receptor NKp46. Science Immunology. 2. PMID 28480349 DOI: 10.1126/sciimmunol.aam9628 |
0.448 |
|
| 2017 |
Cottineau J, Kottemann MC, Lach FP, Kang YH, Vély F, Deenick EK, Lazarov T, Gineau L, Wang Y, Farina A, Chansel M, Lorenzo L, Piperoglou C, Ma CS, Nitschke P, ... ... Vivier E, et al. Inherited GINS1 deficiency underlies growth retardation along with neutropenia and NK cell deficiency. The Journal of Clinical Investigation. PMID 28414293 DOI: 10.1172/Jci90727 |
0.312 |
|
| 2017 |
Baranek T, Morello E, Valayer A, Aimar RF, Bréa D, Henry C, Besnard AG, Dalloneau E, Guillon A, Dequin PF, Narni-Mancinelli E, Vivier E, Laurent F, Wei Y, Paget C, et al. FHL2 Regulates Natural Killer Cell Development and Activation during Streptococcus pneumoniae Infection. Frontiers in Immunology. 8: 123. PMID 28243234 DOI: 10.3389/fimmu.2017.00123 |
0.481 |
|
| 2017 |
Viant C, Guia S, Hennessy RJ, Rautela J, Pham K, Bernat C, Goh W, Jiao Y, Delconte R, Roger M, Simon V, Souza-Fonseca-Guimaraes F, Grabow S, Belz GT, Kile BT, ... ... Vivier E, et al. Cell cycle progression dictates the requirement for BCL2 in natural killer cell survival. The Journal of Experimental Medicine. PMID 28057804 DOI: 10.1084/Jem.20160869 |
0.5 |
|
| 2016 |
Malbec O, Cassard L, Albanesi M, Jönsson F, Mancardi D, Chicanne G, Payrastre B, Dubreuil P, Vivier E, Daëron M. Trans-inhibition of activation and proliferation signals by Fc receptors in mast cells and basophils. Science Signaling. 9: ra126. PMID 27999175 DOI: 10.1126/scisignal.aag1401 |
0.42 |
|
| 2016 |
Chabannon C, Mfarrej B, Guia S, Ugolini S, Devillier R, Blaise D, Vivier E, Calmels B. Manufacturing Natural Killer Cells as Medicinal Products. Frontiers in Immunology. 7: 504. PMID 27895646 DOI: 10.3389/fimmu.2016.00504 |
0.511 |
|
| 2016 |
Vély F, Barlogis V, Vallentin B, Neven B, Piperoglou C, Perchet T, Petit M, Yessaad N, Touzot F, Bruneau J, Mahlaoui N, Zucchini N, Farnarier C, Michel G, Moshous D, ... ... Vivier E, et al. Corrigendum: Evidence of innate lymphoid cell redundancy in humans. Nature Immunology. 17: 1479. PMID 27849206 DOI: 10.1038/ni1216-1479b |
0.379 |
|
| 2016 |
Xu X, Narni-Mancinelli E, Cantoni C, Li Y, Guia S, Gauthier L, Chen Q, Moretta A, Vély F, Eisenstein E, Rangarajan S, Vivier E, Mariuzza RA. Structural Insights into the Inhibitory Mechanism of an Antibody against B7-H6, a Stress-Induced Cellular Ligand for the Natural Killer Cell Receptor NKp30. Journal of Molecular Biology. PMID 27663271 DOI: 10.1016/j.jmb.2016.09.011 |
0.334 |
|
| 2016 |
Beldi-Ferchiou A, Lambert M, Dogniaux S, Vély F, Vivier E, Olive D, Dupuy S, Levasseur F, Zucman D, Lebbé C, Sène D, Hivroz C, Caillat-Zucman S. PD-1 mediates functional exhaustion of activated NK cells in patients with Kaposi sarcoma. Oncotarget. PMID 27662664 DOI: 10.18632/oncotarget.12150 |
0.386 |
|
| 2016 |
Vély F, Barlogis V, Vallentin B, Neven B, Piperoglou C, Perchet T, Petit M, Yessaad N, Touzot F, Bruneau J, Mahlaoui N, Zucchini N, Farnarier C, Michel G, Moshous D, ... ... Vivier E, et al. Evidence of innate lymphoid cell redundancy in humans. Nature Immunology. PMID 27618553 DOI: 10.1038/ni.3553 |
0.416 |
|
| 2016 |
Vivier E, van de Pavert SA, Cooper MD, Belz GT. The evolution of innate lymphoid cells. Nature Immunology. 17: 790-794. PMID 27328009 DOI: 10.1038/Ni.3459 |
0.401 |
|
| 2016 |
Vivier E, Di Santo J, Moretta A. Since their identification 40 years ago, natural killer (NK) cells write a never-ending story. Introduction. Current Topics in Microbiology and Immunology. 395: v-vi. PMID 27222904 |
0.379 |
|
| 2016 |
Ebbo M, Gérard L, Carpentier S, Vély F, Cypowyj S, Farnarier C, Vince N, Malphettes M, Fieschi C, Oksenhendler E, Schleinitz N, Vivier E. Low Circulating Natural Killer Cell Counts are Associated With Severe Disease in Patients With Common Variable Immunodeficiency. Ebiomedicine. 6: 222-30. PMID 27211564 DOI: 10.1016/j.ebiom.2016.02.025 |
0.476 |
|
| 2016 |
Viant C, Rankin LC, Girard-Madoux MJ, Seillet C, Shi W, Smyth MJ, Bartholin L, Walzer T, Huntington ND, Vivier E, Belz GT. Transforming growth factor-β and Notch ligands act as opposing environmental cues in regulating the plasticity of type 3 innate lymphoid cells. Science Signaling. 9: ra46. PMID 27141930 DOI: 10.1126/scisignal.aaf2176 |
0.311 |
|
| 2016 |
Vivier E, Golub R, VanHook AM. Science Signaling Podcast for 3 May 2016: Innate lymphoid cell plasticity. Science Signaling. 9: pc10. PMID 27141927 DOI: 10.1126/Scisignal.Aaf9126 |
0.367 |
|
| 2016 |
Pinhas N, Sternberg-Simon M, Chiossone L, Shahaf G, Walzer T, Vivier E, Mehr R. Murine peripheral NK-cell populations originate from site-specific immature NK cells more than from BM-derived NK cells. European Journal of Immunology. 46: 1258-70. PMID 26919267 DOI: 10.1002/eji.201545847 |
0.48 |
|
| 2016 |
Ludigs K, Jandus C, Utzschneider DT, Staehli F, Bessoles S, Dang AT, Rota G, Castro W, Zehn D, Vivier E, Held W, Romero P, Guarda G. NLRC5 shields T lymphocytes from NK-cell-mediated elimination under inflammatory conditions. Nature Communications. 7: 10554. PMID 26861112 DOI: 10.1038/Ncomms10554 |
0.518 |
|
| 2016 |
Delconte RB, Shi W, Sathe P, Ushiki T, Seillet C, Minnich M, Kolesnik TB, Rankin LC, Mielke LA, Zhang JG, Busslinger M, Smyth MJ, Hutchinson DS, Nutt SL, Nicholson SE, ... ... Vivier E, et al. The Helix-Loop-Helix Protein ID2 Governs NK Cell Fate by Tuning Their Sensitivity to Interleukin-15. Immunity. PMID 26795246 DOI: 10.1016/J.Immuni.2015.12.007 |
0.433 |
|
| 2016 |
Pikovskaya O, Chaix J, Rothman NJ, Collins A, Chen YH, Scipioni AM, Vivier E, Reiner SL. Cutting Edge: Eomesodermin Is Sufficient To Direct Type 1 Innate Lymphocyte Development into the Conventional NK Lineage. Journal of Immunology (Baltimore, Md. : 1950). PMID 26792802 DOI: 10.4049/Jimmunol.1502396 |
0.337 |
|
| 2016 |
Ali AK, Oh JS, Vivier E, Busslinger M, Lee SH. NK Cell-Specific Gata3 Ablation Identifies the Maturation Program Required for Bone Marrow Exit and Control of Proliferation. Journal of Immunology (Baltimore, Md. : 1950). PMID 26773150 DOI: 10.4049/Jimmunol.1501593 |
0.537 |
|
| 2016 |
Vallentin B, Barlogis V, Piperoglou C, Cypowyj S, Zucchini N, Chéné M, Navarro F, Farnarier C, Vivier E, Vély F. Innate Lymphoid Cells in Cancer. Cancer Immunology Research. 3: 1109-14. PMID 26438443 DOI: 10.1158/2326-6066.CIR-15-0222 |
0.496 |
|
| 2016 |
Deauvieau F, Fenis A, Dalençon F, Burdin N, Vivier E, Kerdiles Y. Lessons from NK Cell Deficiencies in the Mouse. Current Topics in Microbiology and Immunology. 395: 173-90. PMID 26385768 DOI: 10.1007/82_2015_473 |
0.51 |
|
| 2015 |
Huntington ND, Carpentier S, Vivier E, Belz GT. Innate lymphoid cells: parallel checkpoints and coordinate interactions with T cells. Current Opinion in Immunology. 38: 86-93. PMID 26736074 DOI: 10.1016/j.coi.2015.11.008 |
0.399 |
|
| 2015 |
Rankin LC, Girard-Madoux MJ, Seillet C, Mielke LA, Kerdiles Y, Fenis A, Wieduwild E, Putoczki T, Mondot S, Lantz O, Demon D, Papenfuss AT, Smyth GK, Lamkanfi M, Carotta S, ... ... Vivier E, et al. Complementarity and redundancy of IL-22-producing innate lymphoid cells. Nature Immunology. PMID 26595889 DOI: 10.1038/ni.3332 |
0.504 |
|
| 2015 |
van de Pavert SA, Vivier E. Differentiation and function of group 3 innate lymphoid cells, from embryo to adult. International Immunology. 28: 35-42. PMID 26374472 DOI: 10.1093/intimm/dxv052 |
0.439 |
|
| 2015 |
Pesce S, Tabellini G, Cantoni C, Patrizi O, Coltrini D, Rampinelli F, Matta J, Vivier E, Moretta A, Parolini S, Marcenaro E. B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape. Oncoimmunology. 4: e1001224. PMID 26137398 DOI: 10.1080/2162402X.2014.1001224 |
0.46 |
|
| 2015 |
Narni-Mancinelli E, Vivier E. Shed NKG2D ligand boosts NK cell immunity. Cell Research. 25: 651-2. PMID 25849247 DOI: 10.1038/cr.2015.41 |
0.441 |
|
| 2015 |
Deng Y, Kerdiles Y, Chu J, Yuan S, Wang Y, Chen X, Mao H, Zhang L, Zhang J, Hughes T, Deng Y, Zhang Q, Wang F, Zou X, Liu CG, ... ... Vivier E, et al. Transcription factor Foxo1 is a negative regulator of natural killer cell maturation and function. Immunity. 42: 457-70. PMID 25769609 DOI: 10.1016/J.Immuni.2015.02.006 |
0.48 |
|
| 2015 |
Gumbleton M, Vivier E, Kerr WG. SHIP1 intrinsically regulates NK cell signaling and education, resulting in tolerance of an MHC class I-mismatched bone marrow graft in mice. Journal of Immunology (Baltimore, Md. : 1950). 194: 2847-54. PMID 25687756 DOI: 10.4049/jimmunol.1402930 |
0.51 |
|
| 2015 |
Eberl G, Di Santo JP, Vivier E. The brave new world of innate lymphoid cells. Nature Immunology. 16: 1-5. PMID 25521670 DOI: 10.1038/Ni.3059 |
0.387 |
|
| 2014 |
Viant C, Fenis A, Chicanne G, Payrastre B, Ugolini S, Vivier E. SHP-1-mediated inhibitory signals promote responsiveness and anti-tumour functions of natural killer cells. Nature Communications. 5: 5108. PMID 25355530 DOI: 10.1038/ncomms6108 |
0.349 |
|
| 2014 |
Sathe P, Delconte RB, Souza-Fonseca-Guimaraes F, Seillet C, Chopin M, Vandenberg CJ, Rankin LC, Mielke LA, Vikstrom I, Kolesnik TB, Nicholson SE, Vivier E, Smyth MJ, Nutt SL, Glaser SP, et al. Innate immunodeficiency following genetic ablation of Mcl1 in natural killer cells. Nature Communications. 5: 4539. PMID 25119382 DOI: 10.1038/ncomms5539 |
0.518 |
|
| 2014 |
Marçais A, Cherfils-Vicini J, Viant C, Degouve S, Viel S, Fenis A, Rabilloud J, Mayol K, Tavares A, Bienvenu J, Gangloff YG, Gilson E, Vivier E, Walzer T. The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells. Nature Immunology. 15: 749-57. PMID 24973821 DOI: 10.1038/Ni.2936 |
0.431 |
|
| 2014 |
Celis-Gutierrez J, Boyron M, Walzer T, Pandolfi PP, Jonji? S, Olive D, Dalod M, Vivier E, Nunès JA. Dok1 and Dok2 proteins regulate natural killer cell development and function. The Embo Journal. 33: 1928-40. PMID 24963146 DOI: 10.15252/Embj.201387404 |
0.572 |
|
| 2014 |
Crouse J, Bedenikovic G, Wiesel M, Ibberson M, Xenarios I, Von Laer D, Kalinke U, Vivier E, Jonjic S, Oxenius A. Type I interferons protect T cells against NK cell attack mediated by the activating receptor NCR1. Immunity. 40: 961-73. PMID 24909889 DOI: 10.1016/J.Immuni.2014.05.003 |
0.526 |
|
| 2014 |
Sun JC, Ugolini S, Vivier E. Immunological memory within the innate immune system Embo Journal. 33: 1295-1303. PMID 24674969 DOI: 10.1002/embj.201387651 |
0.303 |
|
| 2014 |
Kruse PH, Matta J, Ugolini S, Vivier E. Natural cytotoxicity receptors and their ligands. Immunology and Cell Biology. 92: 221-9. PMID 24366519 DOI: 10.1038/icb.2013.98 |
0.465 |
|
| 2014 |
Yan X, Hegab AE, Endo J, Anzai A, Matsuhashi T, Katsumata Y, Ito K, Yamamoto T, Betsuyaku T, Shinmura K, Shen W, Vivier E, Fukuda K, Sano M. Lung natural killer cells play a major counter-regulatory role in pulmonary vascular hyperpermeability after myocardial infarction. Circulation Research. 114: 637-49. PMID 24366170 DOI: 10.1161/CIRCRESAHA.114.302625 |
0.353 |
|
| 2014 |
Kohrt HE, Thielens A, Marabelle A, Sagiv-Barfi I, Sola C, Chanuc F, Fuseri N, Bonnafous C, Czerwinski D, Rajapaksa A, Waller E, Ugolini S, Vivier E, Romagné F, Levy R, et al. Anti-KIR antibody enhancement of anti-lymphoma activity of natural killer cells as monotherapy and in combination with anti-CD20 antibodies. Blood. 123: 678-86. PMID 24326534 DOI: 10.1182/blood-2013-08-519199 |
0.419 |
|
| 2014 |
Speak AO, Te Vruchte D, Davis LC, Morgan AJ, Smith DA, Yanjanin NM, Simmons L, Hartung R, Runz H, Mengel E, Beck M, Imrie J, Jacklin E, Wraith JE, Hendriksz C, ... ... Vivier E, et al. Altered distribution and function of natural killer cells in murine and human Niemann-Pick disease type C1. Blood. 123: 51-60. PMID 24235134 DOI: 10.1182/Blood-2013-03-488692 |
0.434 |
|
| 2014 |
Jouanguy E, Gineau L, Cottineau J, Béziat V, Vivier E, Casanova JL. Inborn errors of the development of human natural killer cells. Current Opinion in Allergy and Clinical Immunology. 13: 589-95. PMID 24135998 DOI: 10.1097/ACI.0000000000000011 |
0.436 |
|
| 2013 |
Firth MA, Madera S, Beaulieu AM, Gasteiger G, Castillo EF, Schluns KS, Kubo M, Rothman PB, Vivier E, Sun JC. Nfil3-independent lineage maintenance and antiviral response of natural killer cells. The Journal of Experimental Medicine. 210: 2981-90. PMID 24277151 DOI: 10.1084/Jem.20130417 |
0.567 |
|
| 2013 |
Vivier E, Ugolini S, Nunès JA. ADAPted secretion of cytokines in NK cells. Nature Immunology. 14: 1108-10. PMID 24145781 DOI: 10.1038/ni.2737 |
0.478 |
|
| 2013 |
Bessoles S, Angelov GS, Back J, Leclercq G, Vivier E, Held W. Education of murine NK cells requires both cis and trans recognition of MHC class I molecules. Journal of Immunology (Baltimore, Md. : 1950). 191: 5044-51. PMID 24098052 DOI: 10.4049/Jimmunol.1301971 |
0.483 |
|
| 2013 |
Rusakiewicz S, Nocturne G, Lazure T, Semeraro M, Flament C, Caillat-Zucman S, Sène D, Delahaye N, Vivier E, Chaba K, Poirier-Colame V, Nordmark G, Eloranta ML, Eriksson P, Theander E, et al. NCR3/NKp30 contributes to pathogenesis in primary Sjogren's syndrome. Science Translational Medicine. 5: 195ra96. PMID 23884468 DOI: 10.1126/Scitranslmed.3005727 |
0.453 |
|
| 2013 |
Biroccio A, Cherfils-Vicini J, Augereau A, Pinte S, Bauwens S, Ye J, Simonet T, Horard B, Jamet K, Cervera L, Mendez-Bermudez A, Poncet D, Grataroli R, de Rodenbeeke CT, Salvati E, ... ... Vivier E, et al. TRF2 inhibits a cell-extrinsic pathway through which natural killer cells eliminate cancer cells. Nature Cell Biology. 15: 818-28. PMID 23792691 DOI: 10.1038/Ncb2774 |
0.507 |
|
| 2013 |
Kerdiles Y, Ugolini S, Vivier E. T cell regulation of natural killer cells. The Journal of Experimental Medicine. 210: 1065-8. PMID 23733834 DOI: 10.1084/jem.20130960 |
0.577 |
|
| 2013 |
Matta J, Baratin M, Chiche L, Forel JM, Cognet C, Thomas G, Farnarier C, Piperoglou C, Papazian L, Chaussabel D, Ugolini S, Vély F, Vivier E. Induction of B7-H6, a ligand for the natural killer cell-activating receptor NKp30, in inflammatory conditions. Blood. 122: 394-404. PMID 23687088 DOI: 10.1182/blood-2013-01-481705 |
0.326 |
|
| 2013 |
Jordan S, Ruzsics Z, Mitrović M, Baranek T, Arapović J, Krmpotić A, Vivier E, Dalod M, Jonjić S, Dölken L, Koszinowski UH. Natural killer cells are required for extramedullary hematopoiesis following murine cytomegalovirus infection. Cell Host & Microbe. 13: 535-545. PMID 23684305 DOI: 10.1016/j.chom.2013.04.007 |
0.51 |
|
| 2013 |
Narni-Mancinelli E, Ugolini S, Vivier E. [Natural killer cells: adaptation and memory in innate immunity]. Medecine Sciences : M/S. 29: 389-95. PMID 23621934 DOI: 10.1051/medsci/2013294012 |
0.501 |
|
| 2013 |
Spits H, Artis D, Colonna M, Diefenbach A, Di Santo JP, Eberl G, Koyasu S, Locksley RM, McKenzie AN, Mebius RE, Powrie F, Vivier E. Innate lymphoid cells--a proposal for uniform nomenclature. Nature Reviews. Immunology. 13: 145-9. PMID 23348417 DOI: 10.1038/Nri3365 |
0.342 |
|
| 2012 |
Narni-Mancinelli E, Ugolini S, Vivier E. Tuning the threshold of natural killer cell responses. Current Opinion in Immunology. 25: 53-8. PMID 23270590 DOI: 10.1016/j.coi.2012.11.005 |
0.501 |
|
| 2012 |
Forel JM, Chiche L, Thomas G, Mancini J, Farnarier C, Cognet C, Guervilly C, Daumas A, Vély F, Xéridat F, Vivier E, Papazian L. Phenotype and functions of natural killer cells in critically-ill septic patients. Plos One. 7: e50446. PMID 23236375 DOI: 10.1371/journal.pone.0050446 |
0.331 |
|
| 2012 |
Tomasello E, Yessaad N, Gregoire E, Hudspeth K, Luci C, Mavilio D, Hardwigsen J, Vivier E. Mapping of NKp46(+) Cells in Healthy Human Lymphoid and Non-Lymphoid Tissues. Frontiers in Immunology. 3: 344. PMID 23181063 DOI: 10.3389/fimmu.2012.00344 |
0.793 |
|
| 2012 |
Alvarez-Breckenridge CA, Yu J, Price R, Wojton J, Pradarelli J, Mao H, Wei M, Wang Y, He S, Hardcastle J, Fernandez SA, Kaur B, Lawler SE, Vivier E, Mandelboim O, et al. NK cells impede glioblastoma virotherapy through NKp30 and NKp46 natural cytotoxicity receptors. Nature Medicine. 18: 1827-34. PMID 23178246 DOI: 10.1038/Nm.3013 |
0.518 |
|
| 2012 |
Baranek T, Manh TP, Alexandre Y, Maqbool MA, Cabeza JZ, Tomasello E, Crozat K, Bessou G, Zucchini N, Robbins SH, Vivier E, Kalinke U, Ferrier P, Dalod M. Differential responses of immune cells to type I interferon contribute to host resistance to viral infection. Cell Host & Microbe. 12: 571-84. PMID 23084923 DOI: 10.1016/j.chom.2012.09.002 |
0.789 |
|
| 2012 |
Jaeger BN, Vivier E. When NK cells overcome their lack of education. The Journal of Clinical Investigation. 122: 3053-6. PMID 22863616 DOI: 10.1172/JCI63524 |
0.408 |
|
| 2012 |
Vivier E, Ugolini S, Blaise D, Chabannon C, Brossay L. Targeting natural killer cells and natural killer T cells in cancer. Nature Reviews. Immunology. 12: 239-52. PMID 22437937 DOI: 10.1038/nri3174 |
0.506 |
|
| 2012 |
Jaeger BN, Donadieu J, Cognet C, Bernat C, Ordoñez-Rueda D, Barlogis V, Mahlaoui N, Fenis A, Narni-Mancinelli E, Beaupain B, Bellanné-Chantelot C, Bajénoff M, Malissen B, Malissen M, Vivier E, et al. Neutrophil depletion impairs natural killer cell maturation, function, and homeostasis. The Journal of Experimental Medicine. 209: 565-80. PMID 22393124 DOI: 10.1084/jem.20111908 |
0.528 |
|
| 2012 |
Jaeger BN, Vivier E. Natural killer cell tolerance: control by self or self-control? Cold Spring Harbor Perspectives in Biology. 4. PMID 22383753 DOI: 10.1101/cshperspect.a007229 |
0.341 |
|
| 2012 |
Gineau L, Cognet C, Kara N, Lach FP, Dunne J, Veturi U, Picard C, Trouillet C, Eidenschenk C, Aoufouchi S, Alcaïs A, Smith O, Geissmann F, Feighery C, Abel L, ... ... Vivier E, et al. Partial MCM4 deficiency in patients with growth retardation, adrenal insufficiency, and natural killer cell deficiency. The Journal of Clinical Investigation. 122: 821-32. PMID 22354167 DOI: 10.1172/Jci61014 |
0.391 |
|
| 2012 |
Narni-Mancinelli E, Vivier E. NK cell genesis: a trick of the trail. Immunity. 36: 1-3. PMID 22284412 DOI: 10.1016/j.immuni.2012.01.001 |
0.44 |
|
| 2012 |
Narni-Mancinelli E, Jaeger BN, Bernat C, Fenis A, Kung S, De Gassart A, Mahmood S, Gut M, Heath SC, Estellé J, Bertosio E, Vely F, Gastinel LN, Beutler B, Malissen B, ... ... Vivier E, et al. Tuning of natural killer cell reactivity by NKp46 and Helios calibrates T cell responses. Science (New York, N.Y.). 335: 344-8. PMID 22267813 DOI: 10.1126/Science.1215621 |
0.55 |
|
| 2012 |
Thielens A, Vivier E, Romagné F. NK cell MHC class I specific receptors (KIR): from biology to clinical intervention. Current Opinion in Immunology. 24: 239-45. PMID 22264929 DOI: 10.1016/j.coi.2012.01.001 |
0.523 |
|
| 2011 |
Narni-Mancinelli E, Chaix J, Fenis A, Kerdiles YM, Yessaad N, Reynders A, Gregoire C, Luche H, Ugolini S, Tomasello E, Walzer T, Vivier E. Fate mapping analysis of lymphoid cells expressing the NKp46 cell surface receptor. Proceedings of the National Academy of Sciences of the United States of America. 108: 18324-9. PMID 22021440 DOI: 10.1073/pnas.1112064108 |
0.831 |
|
| 2011 |
Kaifu T, Escalière B, Gastinel LN, Vivier E, Baratin M. B7-H6/NKp30 interaction: a mechanism of alerting NK cells against tumors. Cellular and Molecular Life Sciences : Cmls. 68: 3531-9. PMID 21877119 DOI: 10.1007/s00018-011-0802-7 |
0.435 |
|
| 2011 |
Reynders A, Yessaad N, Vu Manh TP, Dalod M, Fenis A, Aubry C, Nikitas G, Escalière B, Renauld JC, Dussurget O, Cossart P, Lecuit M, Vivier E, Tomasello E. Identity, regulation and in vivo function of gut NKp46+RORγt+ and NKp46+RORγt- lymphoid cells. The Embo Journal. 30: 2934-47. PMID 21685873 DOI: 10.1038/emboj.2011.201 |
0.802 |
|
| 2011 |
Narni-Mancinelli E, Vivier E, Kerdiles YM. The 'T-cell-ness' of NK cells: unexpected similarities between NK cells and T cells. International Immunology. 23: 427-31. PMID 21665959 DOI: 10.1093/intimm/dxr035 |
0.528 |
|
| 2011 |
Walzer T, Vivier E. G-protein-coupled receptors in control of natural killer cell migration. Trends in Immunology. 32: 486-92. PMID 21664184 DOI: 10.1016/j.it.2011.05.002 |
0.466 |
|
| 2011 |
Romagné F, Vivier E. Natural killer cell-based therapies. F1000 Medicine Reports. 3: 9. PMID 21654924 DOI: 10.3410/M3-9 |
0.466 |
|
| 2011 |
Chiche L, Forel JM, Thomas G, Farnarier C, Vely F, Bléry M, Papazian L, Vivier E. The role of natural killer cells in sepsis. Journal of Biomedicine & Biotechnology. 2011: 986491. PMID 21629707 DOI: 10.1155/2011/986491 |
0.51 |
|
| 2011 |
Delahaye NF, Rusakiewicz S, Martins I, Ménard C, Roux S, Lyonnet L, Paul P, Sarabi M, Chaput N, Semeraro M, Minard-Colin V, Poirier-Colame V, Chaba K, Flament C, Baud V, ... ... Vivier E, et al. Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors. Nature Medicine. 17: 700-7. PMID 21552268 DOI: 10.1038/Nm.2366 |
0.338 |
|
| 2011 |
Guia S, Jaeger BN, Piatek S, Mailfert S, Trombik T, Fenis A, Chevrier N, Walzer T, Kerdiles YM, Marguet D, Vivier E, Ugolini S. Confinement of activating receptors at the plasma membrane controls natural killer cell tolerance. Science Signaling. 4: ra21. PMID 21467299 DOI: 10.1126/Scisignal.2001608 |
0.446 |
|
| 2011 |
Soderquest K, Walzer T, Zafirova B, Klavinskis LS, Polić B, Vivier E, Lord GM, Martín-Fontecha A. Cutting edge: CD8+ T cell priming in the absence of NK cells leads to enhanced memory responses Journal of Immunology. 186: 3304-3308. PMID 21307295 DOI: 10.4049/jimmunol.1004122 |
0.382 |
|
| 2011 |
Crozat K, Eidenschenk C, Jaeger BN, Krebs P, Guia S, Beutler B, Vivier E, Ugolini S. Impact of β2 integrin deficiency on mouse natural killer cell development and function Blood. 117: 2874-2882. PMID 21239699 DOI: 10.1182/Blood-2010-10-315457 |
0.499 |
|
| 2011 |
Vivier E, Raulet DH, Moretta A, Caligiuri MA, Zitvogel L, Lanier LL, Yokoyama WM, Ugolini S. Innate or adaptive immunity? The example of natural killer cells. Science (New York, N.Y.). 331: 44-9. PMID 21212348 DOI: 10.1126/Science.1198687 |
0.51 |
|
| 2010 |
Schleinitz N, Vély F, Harlé JR, Vivier E. Natural killer cells in human autoimmune diseases. Immunology. 131: 451-8. PMID 21039469 DOI: 10.1111/j.1365-2567.2010.03360.x |
0.439 |
|
| 2010 |
Chauveau A, Aucher A, Eissmann P, Vivier E, Davis DM. Membrane nanotubes facilitate long-distance interactions between natural killer cells and target cells. Proceedings of the National Academy of Sciences of the United States of America. 107: 5545-50. PMID 20212116 DOI: 10.1073/pnas.0910074107 |
0.454 |
|
| 2010 |
Baratin M, Vivier E. [B7-H6 : a novel alert signal for NK cells]. Medecine Sciences : M/S. 26: 119-20. PMID 20188033 DOI: 10.1051/medsci/2010262119 |
0.341 |
|
| 2010 |
Cognet C, Farnarier C, Gauthier L, Frassati C, André P, Magérus-Chatinet A, Anfossi N, Rieux-Laucat F, Vivier E, Schleinitz N. Expression of the HLA-C2-specific activating killer-cell Ig-like receptor KIR2DS1 on NK and T cells. Clinical Immunology (Orlando, Fla.). 135: 26-32. PMID 20093094 DOI: 10.1016/j.clim.2009.12.009 |
0.483 |
|
| 2010 |
Vivier E, Ugolini S. Regulatory natural killer cells: new players in the IL-10 anti-inflammatory response. Cell Host & Microbe. 6: 493-5. PMID 20006835 DOI: 10.1016/j.chom.2009.12.001 |
0.428 |
|
| 2009 |
Tomasello E, Reynders A, Vivier E. A novel mucosal RORγtNKp46 cell subset is a source of interleukin-22. F1000 Biology Reports. 1: 28. PMID 20948658 DOI: 10.3410/B1-28 |
0.812 |
|
| 2009 |
Romagné F, André P, Spee P, Zahn S, Anfossi N, Gauthier L, Capanni M, Ruggeri L, Benson DM, Blaser BW, Della Chiesa M, Moretta A, Vivier E, Caligiuri MA, Velardi A, et al. Preclinical characterization of 1-7F9, a novel human anti-KIR receptor therapeutic antibody that augments natural killer-mediated killing of tumor cells. Blood. 114: 2667-77. PMID 19553639 DOI: 10.1182/Blood-2009-02-206532 |
0.418 |
|
| 2009 |
Brandt CS, Baratin M, Yi EC, Kennedy J, Gao Z, Fox B, Haldeman B, Ostrander CD, Kaifu T, Chabannon C, Moretta A, West R, Xu W, Vivier E, Levin SD. The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans. The Journal of Experimental Medicine. 206: 1495-503. PMID 19528259 DOI: 10.1084/jem.20090681 |
0.44 |
|
| 2009 |
Joncker NT, Fernandez NC, Treiner E, Vivier E, Raulet DH. NK cell responsiveness is tuned commensurate with the number of inhibitory receptors for self-MHC class I: the rheostat model. Journal of Immunology (Baltimore, Md. : 1950). 182: 4572-80. PMID 19342631 DOI: 10.4049/Jimmunol.0803900 |
0.428 |
|
| 2009 |
Vivier E, Spits H, Cupedo T. Interleukin-22-producing innate immune cells: new players in mucosal immunity and tissue repair? Nature Reviews. Immunology. 9: 229-34. PMID 19319141 DOI: 10.1038/nri2522 |
0.391 |
|
| 2009 |
Lapaque N, Walzer T, Méresse S, Vivier E, Trowsdale J. Interactions between human NK cells and macrophages in response to Salmonella infection. Journal of Immunology (Baltimore, Md. : 1950). 182: 4339-48. PMID 19299734 DOI: 10.4049/jimmunol.0803329 |
0.421 |
|
| 2009 |
Chiossone L, Chaix J, Fuseri N, Roth C, Vivier E, Walzer T. Maturation of mouse NK cells is a 4-stage developmental program. Blood. 113: 5488-96. PMID 19234143 DOI: 10.1182/blood-2008-10-187179 |
0.441 |
|
| 2009 |
Ugolini S, Vivier E. Immunology: Natural killer cells remember. Nature. 457: 544-5. PMID 19177118 DOI: 10.1038/457544a |
0.494 |
|
| 2009 |
Crozat K, Vivier E, Dalod M. Crosstalk between components of the innate immune system: promoting anti-microbial defenses and avoiding immunopathologies. Immunological Reviews. 227: 129-49. PMID 19120481 DOI: 10.1111/j.1600-065X.2008.00736.x |
0.363 |
|
| 2009 |
Luci C, Reynders A, Ivanov II, Cognet C, Chiche L, Chasson L, Hardwigsen J, Anguiano E, Banchereau J, Chaussabel D, Dalod M, Littman DR, Vivier E, Tomasello E. Influence of the transcription factor RORgammat on the development of NKp46+ cell populations in gut and skin. Nature Immunology. 10: 75-82. PMID 19029904 DOI: 10.1038/Ni.1681 |
0.804 |
|
| 2008 |
Schreeder DM, Pan J, Li FJ, Vivier E, Davis RS. FCRL6 distinguishes mature cytotoxic lymphocytes and is upregulated in patients with B-cell chronic lymphocytic leukemia. European Journal of Immunology. 38: 3159-66. PMID 18991291 DOI: 10.1002/eji.200838516 |
0.495 |
|
| 2008 |
Despoix N, Walzer T, Jouve N, Blot-Chabaud M, Bardin N, Paul P, Lyonnet L, Vivier E, Dignat-George F, Vély F. Mouse CD146/MCAM is a marker of natural killer cell maturation. European Journal of Immunology. 38: 2855-64. PMID 18958886 DOI: 10.1002/eji.200838469 |
0.341 |
|
| 2008 |
Helming L, Tomasello E, Kyriakides TR, Martinez FO, Takai T, Gordon S, Vivier E. Essential role of DAP12 signaling in macrophage programming into a fusion-competent state. Science Signaling. 1: ra11. PMID 18957693 DOI: 10.1126/Scisignal.1159665 |
0.714 |
|
| 2008 |
Pende D, Marcenaro S, Falco M, Martini S, Bernardo ME, Montagna D, Romeo E, Cognet C, Martinetti M, Maccario R, Mingari MC, Vivier E, Moretta L, Locatelli F, Moretta A. Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity. Blood. 113: 3119-29. PMID 18945967 DOI: 10.1182/blood-2008-06-164103 |
0.411 |
|
| 2008 |
Hall HT, Sjölin H, Brauner H, Tomasello E, Dalod M, Vivier E, Höglund P. Increased diabetes development and decreased function of CD4+CD25+ Treg in the absence of a functional DAP12 adaptor protein. European Journal of Immunology. 38: 3191-9. PMID 18925576 DOI: 10.1002/eji.200838259 |
0.753 |
|
| 2008 |
Schleinitz N, Cognet C, Guia S, Laugier-Anfossi F, Baratin M, Pouget J, Pelissier J, Harle J, Vivier E, Figarella-Branger D. Expression of the CD85j (Leukocyte Ig-like Receptor 1, Ig-like Transcript 2) Receptor for Class I Major Histocompatibility Complex Molecules in Idiopathic Inflammatory Myopathies Arthritis & Rheumatism. 58: 3216-3223. PMID 18821690 DOI: 10.1002/Art.23871 |
0.343 |
|
| 2008 |
Grégoire C, Cognet C, Chasson L, Coupet CA, Dalod M, Reboldi A, Marvel J, Sallusto F, Vivier E, Walzer T. Intrasplenic trafficking of natural killer cells is redirected by chemokines upon inflammation. European Journal of Immunology. 38: 2076-84. PMID 18624307 DOI: 10.1002/eji.200838550 |
0.497 |
|
| 2008 |
Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S. Functions of natural killer cells. Nature Immunology. 9: 503-10. PMID 18425107 DOI: 10.1038/ni1582 |
0.8 |
|
| 2008 |
Guia S, Cognet C, De Beaucoudrey L, Tessmer MS, Jouanguy E, Berger C, Filipe-Santos O, Feinberg J, Camcioglu Y, Levy J, Jumaah SA, Al-Hajjar S, Stephan JL, Fieschi C, Abel L, ... ... Vivier E, et al. A role for interleukin-12/23 in the maturation of human natural killer and CD56 + T cells in vivo Blood. 111: 5008-5016. PMID 18319400 DOI: 10.1182/blood-2007-11-122259 |
0.34 |
|
| 2008 |
Coudert JD, Scarpellino L, Gros F, Vivier E, Held W. Sustained NKG2D engagement induces cross-tolerance of multiple distinct NK cell activation pathways. Blood. 111: 3571-8. PMID 18198346 DOI: 10.1182/Blood-2007-07-100057 |
0.548 |
|
| 2008 |
Grégoire C, Chasson L, Luci C, Tomasello E, Geissmann F, Vivier E, Walzer T. The trafficking of natural killer cells. Immunological Reviews. 220: 169-82. PMID 17979846 DOI: 10.1111/j.1600-065X.2007.00563.x |
0.794 |
|
| 2007 |
Walzer T, Chiossone L, Chaix J, Calver A, Carozzo C, Garrigue-Antar L, Jacques Y, Baratin M, Tomasello E, Vivier E. Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor. Nature Immunology. 8: 1337-44. PMID 17965716 DOI: 10.1038/ni1523 |
0.771 |
|
| 2007 |
Ku CL, von Bernuth H, Picard C, Zhang SY, Chang HH, Yang K, Chrabieh M, Issekutz AC, Cunningham CK, Gallin J, Holland SM, Roifman C, Ehl S, Smart J, Tang M, ... ... Vivier E, et al. Selective predisposition to bacterial infections in IRAK-4-deficient children: IRAK-4-dependent TLRs are otherwise redundant in protective immunity. The Journal of Experimental Medicine. 204: 2407-22. PMID 17893200 DOI: 10.1084/Jem.20070628 |
0.346 |
|
| 2007 |
Robbins SH, Bessou G, Cornillon A, Zucchini N, Rupp B, Ruzsics Z, Sacher T, Tomasello E, Vivier E, Koszinowski UH, Dalod M. Natural killer cells promote early CD8 T cell responses against cytomegalovirus. Plos Pathogens. 3: e123. PMID 17722980 DOI: 10.1371/journal.ppat.0030123 |
0.788 |
|
| 2007 |
Bonorino P, Leroy V, Dufeu-Duchesne T, Tongiani-Dashan S, Sturm N, Pernollet M, Vivier E, Zarski JP, Marche PN, Jouvin-Marche E. Features and distribution of CD8 T cells with human leukocyte antigen class I-specific receptor expression in chronic hepatitis C. Hepatology (Baltimore, Md.). 46: 1375-86. PMID 17668887 DOI: 10.1002/hep.21850 |
0.351 |
|
| 2007 |
Stewart CA, Walzer T, Robbins SH, Malissen B, Vivier E, Prinz I. Germ-line rearranged Tcrd transcription distinguish bona fide NK cells and NK-like γδ T cells European Journal of Immunology. 37: 1442-1452. PMID 17492716 DOI: 10.1002/eji.200737354 |
0.566 |
|
| 2007 |
Besson C, Roetynck S, Williams F, Orsi L, Amiel C, Lependeven C, Antoni G, Hermine O, Brice P, Ferme C, Carde P, Canioni D, Brière J, Raphael M, Nicolas JC, ... ... Vivier E, et al. Association of killer cell immunoglobulin-like receptor genes with Hodgkin's lymphoma in a familial study. Plos One. 2: e406. PMID 17476328 DOI: 10.1371/journal.pone.0000406 |
0.43 |
|
| 2007 |
Walzer T, Jaeger S, Chaix J, Vivier E. Natural killer cells: from CD3-NKp46+ to post-genomics meta-analyses Current Opinion in Immunology. 19: 365-372. PMID 17442558 DOI: 10.1016/j.coi.2007.04.004 |
0.497 |
|
| 2007 |
Crozat K, Hoebe K, Ugolini S, Hong NA, Janssen E, Rutschmann S, Mudd S, Sovath S, Vivier E, Beutler B. Jinx, an MCMV susceptibility phenotype caused by disruption of Unc13d: a mouse model of type 3 familial hemophagocytic lymphohistiocytosis Journal of Experimental Medicine. 204: 853-863. PMID 17420270 DOI: 10.1084/Jem.20062447 |
0.346 |
|
| 2007 |
Walzer T, Bléry M, Chaix J, Fuseri N, Chasson L, Robbins SH, Jaeger S, André P, Gauthier L, Daniel L, Chemin K, Morel Y, Dalod M, Imbert J, Pierres M, ... ... Vivier E, et al. Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46. Proceedings of the National Academy of Sciences of the United States of America. 104: 3384-9. PMID 17360655 DOI: 10.1073/Pnas.0609692104 |
0.571 |
|
| 2007 |
Baratin M, Roetynck S, Pouvelle B, Lemmers C, Viebig NK, Johansson S, Bierling P, Scherf A, Gysin J, Vivier E, Ugolini S. Dissection of the role of PfEMP1 and ICAM-1 in the sensing of Plasmodium-falciparum-infected erythrocytes by natural killer cells. Plos One. 2: e228. PMID 17311092 DOI: 10.1371/Journal.Pone.0000228 |
0.352 |
|
| 2007 |
Nedvetzki S, Sowinski S, Eagle RA, Harris J, Vély F, Pende D, Trowsdale J, Vivier E, Gordon S, Davis DM. Reciprocal regulation of human natural killer cells and macrophages associated with distinct immune synapses. Blood. 109: 3776-85. PMID 17218381 DOI: 10.1182/Blood-2006-10-052977 |
0.538 |
|
| 2007 |
Eidenschenk C, Jouanguy E, Alcaïs A, Mention JJ, Pasquier B, Fleckenstein IM, Puel A, Gineau L, Carel JC, Vivier E, Le Deist F, Casanova JL. Familial NK cell deficiency associated with impaired IL-2- and IL-15-dependent survival of lymphocytes. Journal of Immunology (Baltimore, Md. : 1950). 177: 8835-43. PMID 17142786 DOI: 10.4049/jimmunol.177.12.8835 |
0.397 |
|
| 2007 |
Roetynck S, Baratin M, Johansson S, Lemmers C, Vivier E, Ugolini S. Natural killer cells and malaria. Immunological Reviews. 214: 251-63. PMID 17100890 DOI: 10.1111/j.1600-065X.2006.00446.x |
0.433 |
|
| 2006 |
French AR, Sjölin H, Kim S, Koka R, Yang L, Young DA, Cerboni C, Tomasello E, Ma A, Vivier E, Kärre K, Yokoyama WM. DAP12 signaling directly augments proproliferative cytokine stimulation of NK cells during viral infections. Journal of Immunology (Baltimore, Md. : 1950). 177: 4981-90. PMID 17015680 DOI: 10.4049/Jimmunol.177.8.4981 |
0.792 |
|
| 2006 |
Roetynck S, Baratin M, Vivier E, Ugolini S. [NK cells and innate immunity to malaria]. Medecine Sciences : M/S. 22: 739-44. PMID 16962049 DOI: 10.1051/medsci/20062289739 |
0.495 |
|
| 2006 |
Vivier E. What is natural in natural killer cells? Immunology Letters. 107: 1-7. PMID 16930725 DOI: 10.1016/j.imlet.2006.07.004 |
0.537 |
|
| 2006 |
Sjölin H, Robbins SH, Bessou G, Hidmark A, Tomasello E, Johansson M, Hall H, Charifi F, Karlsson Hedestam GB, Biron CA, Kärre K, Höglund P, Vivier E, Dalod M. DAP12 signaling regulates plasmacytoid dendritic cell homeostasis and down-modulates their function during viral infection. Journal of Immunology (Baltimore, Md. : 1950). 177: 2908-16. PMID 16920926 DOI: 10.4049/Jimmunol.177.5.2908 |
0.729 |
|
| 2006 |
Anfossi N, André P, Guia S, Falk CS, Roetynck S, Stewart CA, Breso V, Frassati C, Reviron D, Middleton D, Romagné F, Ugolini S, Vivier E. Human NK cell education by inhibitory receptors for MHC class I. Immunity. 25: 331-42. PMID 16901727 DOI: 10.1016/j.immuni.2006.06.013 |
0.448 |
|
| 2006 |
Walzer T, Vivier E. NK cell development: gas matters. Nature Immunology. 7: 702-4. PMID 16785886 DOI: 10.1038/ni0706-702 |
0.31 |
|
| 2006 |
Taieb J, Chaput N, Ménard C, Apetoh L, Ullrich E, Bonmort M, Péquignot M, Casares N, Terme M, Flament C, Opolon P, Lecluse Y, Métivier D, Tomasello E, Vivier E, et al. A novel dendritic cell subset involved in tumor immunosurveillance. Nature Medicine. 12: 214-9. PMID 16444265 DOI: 10.1038/Nm1356 |
0.783 |
|
| 2006 |
Chiesa S, Mingueneau M, Fuseri N, Malissen B, Raulet DH, Malissen M, Vivier E, Tomasello E. Multiplicity and plasticity of natural killer cell signaling pathways. Blood. 107: 2364-72. PMID 16291591 DOI: 10.1182/Blood-2005-08-3504 |
0.802 |
|
| 2006 |
Ghiringhelli F, Ménard C, Terme M, Flament C, Taieb J, Chaput N, Puig PE, Novault S, Escudier B, Vivier E, Lecesne A, Robert C, Blay JY, Bernard J, Caillat-Zucman S, et al. CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner. The Journal of Experimental Medicine. 202: 1075-85. PMID 16230475 DOI: 10.1084/jem.20051511 |
0.509 |
|
| 2006 |
Walzer T, Dalod M, Vivier E, Zitvogel L. Natural killer cell-dendritic cell crosstalk in the initiation of immune responses. Expert Opinion On Biological Therapy. S49-59. PMID 16187940 DOI: 10.1517/14712598.5.1.s49 |
0.484 |
|
| 2005 |
Orabona C, Tomasello E, Fallarino F, Bianchi R, Volpi C, Bellocchio S, Romani L, Fioretti MC, Vivier E, Puccetti P, Grohmann U. Enhanced tryptophan catabolism in the absence of the molecular adapter DAP12. European Journal of Immunology. 35: 3111-8. PMID 16206234 DOI: 10.1002/eji.200535289 |
0.74 |
|
| 2005 |
Baratin M, Roetynck S, Lépolard C, Falk C, Sawadogo S, Uematsu S, Akira S, Ryffel B, Tiraby JG, Alexopoulou L, Kirschning CJ, Gysin J, Vivier E, Ugolini S. Natural killer cell and macrophage cooperation in MyD88-dependent innate responses to Plasmodium falciparum. Proceedings of the National Academy of Sciences of the United States of America. 102: 14747-52. PMID 16203971 DOI: 10.1073/Pnas.0507355102 |
0.511 |
|
| 2005 |
Stewart CA, Laugier-Anfossi F, Vély F, Saulquin X, Riedmuller J, Tisserant A, Gauthier L, Romagné F, Ferracci G, Arosa FA, Moretta A, Sun PD, Ugolini S, Vivier E. Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors. Proceedings of the National Academy of Sciences of the United States of America. 102: 13224-9. PMID 16141329 DOI: 10.1073/pnas.0503594102 |
0.36 |
|
| 2005 |
Vély F, Vivier E. Natural killer cell receptor signaling pathway in mammals. Science's Stke : Signal Transduction Knowledge Environment. 2005: cm7. PMID 16014604 DOI: 10.1126/stke.2922005cm7 |
0.505 |
|
| 2005 |
Vély F, Vivier E. Natural killer cell receptor signaling pathway. Science's Stke : Signal Transduction Knowledge Environment. 2005: cm6. PMID 16014603 DOI: 10.1126/stke.2922005cm6 |
0.515 |
|
| 2005 |
Walzer T, Dalod M, Robbins SH, Zitvogel L, Vivier E. Natural-killer cells and dendritic cells: "L'union fait la force" Blood. 106: 2252-2258. PMID 15933055 DOI: 10.1182/blood-2005-03-1154 |
0.526 |
|
| 2005 |
Coudert JD, Zimmer J, Tomasello E, Cebecauer M, Colonna M, Vivier E, Held W. Altered NKG2D function in NK cells induced by chronic exposure to NKG2D ligand-expressing tumor cells. Blood. 106: 1711-7. PMID 15886320 DOI: 10.1182/Blood-2005-03-0918 |
0.777 |
|
| 2005 |
Tomasello E, Vivier E. KARAP/DAP12/TYROBP: three names and a multiplicity of biological functions. European Journal of Immunology. 35: 1670-7. PMID 15884055 DOI: 10.1002/eji.200425932 |
0.78 |
|
| 2005 |
Lafarge X, Pitard V, Ravet S, Roumanes D, Halary F, Dromer C, Vivier E, Paul P, Moreau JF, Déchanet-Merville J. Expression of MHC class I receptors confers functional intraclonal heterogeneity to a reactive expansion of gammadelta T cells. European Journal of Immunology. 35: 1896-905. PMID 15864777 DOI: 10.1002/eji.200425837 |
0.459 |
|
| 2005 |
Nataf S, Anginot A, Vuaillat C, Malaval L, Fodil N, Chereul E, Langlois JB, Dumontel C, Cavillon G, Confavreux C, Mazzorana M, Vico L, Belin MF, Vivier E, Tomasello E, et al. Brain and bone damage in KARAP/DAP12 loss-of-function mice correlate with alterations in microglia and osteoclast lineages. The American Journal of Pathology. 166: 275-86. PMID 15632019 DOI: 10.1016/S0002-9440(10)62251-1 |
0.634 |
|
| 2005 |
Chiesa S, Tomasello E, Vivier E, Vély F. Coordination of activating and inhibitory signals in natural killer cells. Molecular Immunology. 42: 477-84. PMID 15607802 DOI: 10.1016/j.molimm.2004.07.030 |
0.745 |
|
| 2005 |
Avril T, Floyd H, Lopez F, Vivier E, Crocker PR. The membrane-proximal immunoreceptor tyrosine-based inhibitory motif is critical for the inhibitory signaling mediated by Siglecs-7 and -9, CD33-related Siglecs expressed on human monocytes and NK cells. Journal of Immunology (Baltimore, Md. : 1950). 173: 6841-9. PMID 15557178 DOI: 10.4049/jimmunol.173.11.6841 |
0.36 |
|
| 2004 |
Roumier A, Béchade C, Poncer JC, Smalla KH, Tomasello E, Vivier E, Gundelfinger ED, Triller A, Bessis A. Impaired synaptic function in the microglial KARAP/DAP12-deficient mouse. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 11421-8. PMID 15601948 DOI: 10.1523/Jneurosci.2251-04.2004 |
0.678 |
|
| 2004 |
Anfossi N, Doisne JM, Peyrat MA, Ugolini S, Bonnaud O, Bossy D, Pitard V, Merville P, Moreau JF, Delfraissy JF, Dechanet-Merville J, Bonneville M, Venet A, Vivier E. Coordinated expression of Ig-like inhibitory MHC class I receptors and acquisition of cytotoxic function in human CD8+ T cells. Journal of Immunology (Baltimore, Md. : 1950). 173: 7223-9. PMID 15585844 |
0.381 |
|
| 2004 |
Vivier E, Nunès JA, Vély F. Natural killer cell signaling pathways. Science (New York, N.Y.). 306: 1517-9. PMID 15567854 DOI: 10.1126/science.1103478 |
0.553 |
|
| 2004 |
Pascal V, Schleinitz N, Brunet C, Ravet S, Bonnet E, Lafarge X, Touinssi M, Reviron D, Viallard JF, Moreau JF, Déchanet-Merville J, Blanco P, Harlé JR, Sampol J, Vivier E, et al. Comparative analysis of NK cell subset distribution in normal and lymphoproliferative disease of granular lymphocyte conditions. European Journal of Immunology. 34: 2930-40. PMID 15368309 DOI: 10.1002/eji.200425146 |
0.499 |
|
| 2004 |
Anfossi N, Robbins SH, Ugolini S, Georgel P, Hoebe K, Bouneaud C, Ronet C, Kaser A, DiCioccio CB, Tomasello E, Blumberg RS, Beutler B, Reiner SL, Alexopoulou L, Lantz O, ... ... Vivier E, et al. Expansion and function of CD8+ T cells expressing Ly49 inhibitory receptors specific for MHC class I molecules. Journal of Immunology (Baltimore, Md. : 1950). 173: 3773-82. PMID 15356124 DOI: 10.4049/Jimmunol.173.6.3773 |
0.744 |
|
| 2004 |
Oberg L, Johansson S, Michaëlsson J, Tomasello E, Vivier E, Kärre K, Höglund P. Loss or mismatch of MHC class I is sufficient to trigger NK cell-mediated rejection of resting lymphocytes in vivo - role of KARAP/DAP12-dependent and -independent pathways. European Journal of Immunology. 34: 1646-53. PMID 15162434 DOI: 10.1002/eji.200424913 |
0.778 |
|
| 2004 |
Terme M, Tomasello E, Maruyama K, Crépineau F, Chaput N, Flament C, Marolleau JP, Angevin E, Wagner EF, Salomon B, Lemonnier FA, Wakasugi H, Colonna M, Vivier E, Zitvogel L. IL-4 confers NK stimulatory capacity to murine dendritic cells: a signaling pathway involving KARAP/DAP12-triggering receptor expressed on myeloid cell 2 molecules. Journal of Immunology (Baltimore, Md. : 1950). 172: 5957-66. PMID 15128777 DOI: 10.4049/Jimmunol.172.10.5957 |
0.787 |
|
| 2004 |
André P, Castriconi R, Espéli M, Anfossi N, Juarez T, Hue S, Conway H, Romagné F, Dondero A, Nanni M, Caillat-Zucman S, Raulet DH, Bottino C, Vivier E, Moretta A, et al. Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors. European Journal of Immunology. 34: 961-71. PMID 15048706 DOI: 10.1002/Eji.200324705 |
0.478 |
|
| 2004 |
Vivier E, Anfossi N. Inhibitory NK-cell receptors on T cells: witness of the past, actors of the future. Nature Reviews. Immunology. 4: 190-8. PMID 15039756 DOI: 10.1038/nri1306 |
0.495 |
|
| 2003 |
Anfossi N, Lucas M, Diefenbach A, Bühring HJ, Raulet D, Tomasello E, Vivier E. Contrasting roles of DAP10 and KARAP/DAP12 signaling adaptors in activation of the RBL-2H3 leukemic mast cell line European Journal of Immunology. 33: 3514-3522. PMID 14635062 DOI: 10.1002/Eji.200324573 |
0.717 |
|
| 2003 |
Ferjoux G, Lopez F, Esteve JP, Ferrand A, Vivier E, Vely F, Saint-Laurent N, Pradayrol L, Buscail L, Susini C. Critical role of Src and SHP-2 in sst2 somatostatin receptor-mediated activation of SHP-1 and inhibition of cell proliferation. Molecular Biology of the Cell. 14: 3911-28. PMID 12972574 DOI: 10.1091/mbc.e03-02-0069 |
0.347 |
|
| 2003 |
Saulquin X, Gastinel LN, Vivier E. Crystal structure of the human natural killer cell activating receptor KIR2DS2 (CD158j). The Journal of Experimental Medicine. 197: 933-8. PMID 12668644 DOI: 10.1084/jem.20021624 |
0.383 |
|
| 2003 |
Snyder MR, Lucas M, Vivier E, Weyand CM, Goronzy JJ. Selective activation of the c-Jun NH2-terminal protein kinase signaling pathway by stimulatory KIR in the absence of KARAP/DAP12 in CD4+ T cells. The Journal of Experimental Medicine. 197: 437-49. PMID 12591902 DOI: 10.1084/jem.20020383 |
0.367 |
|
| 2002 |
Diefenbach A, Tomasello E, Lucas M, Jamieson AM, Hsia JK, Vivier E, Raulet DH. Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D. Nature Immunology. 3: 1142-9. PMID 12426565 DOI: 10.1038/Ni858 |
0.748 |
|
| 2002 |
Lucas M, Daniel L, Tomasello E, Guia S, Horschowski N, Aoki N, Figarella-Branger D, Gomez S, Vivier E. Massive inflammatory syndrome and lymphocytic immunodeficiency in KARAP/DAP12-transgenic mice. European Journal of Immunology. 32: 2653-63. PMID 12207350 DOI: 10.1002/1521-4141(200209)32:9<2653::Aid-Immu2653>3.0.Co;2-V |
0.68 |
|
| 2002 |
Vivier E, Biron CA. Immunology. A pathogen receptor on natural killer cells. Science (New York, N.Y.). 296: 1248-9. PMID 12016296 DOI: 10.1126/Science.1072447 |
0.44 |
|
| 2002 |
Vivier E, Tomasello E, Paul P. Lymphocyte activation via NKG2D: towards a new paradigm in immune recognition? Current Opinion in Immunology. 14: 306-11. PMID 11973127 DOI: 10.1016/s0952-7915(02)00337-0 |
0.801 |
|
| 2002 |
Fernandez NC, Flament C, Crépineau F, Angevin E, Vivier E, Zitvogel L. Dendritic cells (DC) promote natural killer (NK) cell functions: dynamics of the human DC/NK cell cross talk. European Cytokine Network. 13: 17-27. PMID 11956017 |
0.519 |
|
| 2002 |
Sjölin H, Tomasello E, Mousavi-Jazi M, Bartolazzi A, Kärre K, Vivier E, Cerboni C. Pivotal role of KARAP/DAP12 adaptor molecule in the natural killer cell-mediated resistance to murine cytomegalovirus infection. The Journal of Experimental Medicine. 195: 825-34. PMID 11927627 DOI: 10.1084/jem.20011427 |
0.791 |
|
| 2002 |
Jiang K, Zhong B, Gilvary DL, Corliss BC, Vivier E, Hong-Geller E, Wei S, Djeu JY. Syk regulation of phosphoinositide 3-kinase-dependent NK cell function. Journal of Immunology (Baltimore, Md. : 1950). 168: 3155-64. PMID 11907067 DOI: 10.4049/jimmunol.168.7.3155 |
0.41 |
|
| 2002 |
Colucci F, Schweighoffer E, Tomasello E, Turner M, Ortaldo JR, Vivier E, Tybulewicz VL, Di Santo JP. Natural cytotoxicity uncoupled from the Syk and ZAP-70 intracellular kinases. Nature Immunology. 3: 288-94. PMID 11836527 DOI: 10.1038/Ni764 |
0.783 |
|
| Show low-probability matches. |